Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia

T J Marrie1, D Raoult, B La Scola

  • 1Department of Medicine, University of Alberta, Edmonton, Canada. tom.marrie@ualberta.ca

Insights

Legionella-like amoebal pathogens (LLAPs) are infrequently involved in community-acquired pneumonia. These LLAPs can act as a sole pathogen or co-pathogen in pneumonia cases.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Immunology

Background:

  • Community-acquired pneumonia (CAP) is a significant global health concern.
  • The etiology of CAP is diverse, involving numerous bacterial, viral, and fungal pathogens.
  • The role of less common or emerging pathogens in CAP requires further investigation.

Observation:

  • Serum specimens from pneumonia patients were tested using indirect immunofluorescence.
  • The testing targeted Legionella-like amoebal pathogens (LLAPs) 1-7, 9, 10, 12, 13.
  • Additional targets included Parachlamydia acanthamoeba strains and Afipia felis.

Findings:

  • Legionella-like amoebal pathogens (LLAPs) were identified in a subset of pneumonia cases.
  • LLAPs were found to play an infrequent role in community-acquired pneumonia.
  • In some instances, LLAPs acted as the sole identified pathogen, while in others, they were co-pathogens.

Implications:

  • These findings suggest LLAPs should be considered in the differential diagnosis of CAP.
  • Further research is warranted to understand the prevalence and clinical significance of LLAPs in pneumonia.
  • Improved diagnostic approaches may be needed to detect LLAP infections effectively.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...